critical

Clarifai Recognized as a Challenger and Fast Mover in GigaOm Radar for AI Infrastructure Report

WASHINGTON, July 24, 2025 /PRNewswire/ -- Clarifai, a global leader in AI and pioneer of the full-stack AI platform, announced…

2 months ago

Drger Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation

Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in patient outcomes, clinical efficiency, cost-effectiveness and critical care…

2 months ago

Asteroid Day Gains Momentum with U.S. Recognition from Flagstaff, Coconino County, U.S. Senate, and Vera C. Rubin Observatory Data Release

LUXEMBOURG, June 25, 2025 /PRNewswire/ -- The Asteroid Foundation, working in collaboration with B612 Foundation, founding sponsor of Asteroid Day,…

2 months ago

GW Instek Unveils Full Smart Measurement Portfolio to Accelerate Next-Gen Industrial Testing

TAIPEI, July 8, 2025 /PRNewswire/ -- In response to the global surge in industrial automation and smart manufacturing, precision data…

2 months ago

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration Day, the International Institute of Refrigeration (IIR) is calling…

2 months ago

VdoCipher’s Piracy Detection Engine Blocks 250,000+ Video Piracy Attempts in 12 Months

GURUGRAM, India, July 2, 2025 /PRNewswire/ -- In today's digital world, protecting premium video content is more critical than ever.…

2 months ago

TraceLink’s MINT Named “Supply Chain Transparency Solution of the Year” in 2025 SupplyTech Breakthrough Awards

The award recognizes MINT for enabling real-time, end-to-end visibility across critical supply chain transactions and processes BOSTON, July 1, 2025…

2 months ago

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…

3 months ago

MSCI Announces the Results of the MSCI 2025 Global Market Accessibility Review

NEW YORK--(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment…

3 months ago

Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026

COPENHAGEN, Denmark, June 18, 2025 /PRNewswire/ -- Droplet IV today announced the successful completion of a $2 million funding round…

3 months ago